Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Incyte to Report First Quarter 2012 Financial Results on April 26

Incyte Corporation
Posted on: 11 Apr 12

Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its first quarter 2012 financial results conference call for 8:30 a.m. ET on Thursday, April 26, 2012. The schedules for the press release and conference call are as follows:

-- Q1 2012 Press Release: April 26, 2012 at 7:00 a.m. ET
-- Q1 2012 Conference Call: April 26, 2012 at 8:30 a.m. ET
-- Domestic Dial In Number: 877-407-8037
-- International Dial In Number: 201-689-8037
-- Conference ID # 391589

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 391589.

The conference call will also be webcast live and can be accessed at under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at

Business Wire

Last updated on: 11/04/2012

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.